📣 VC round data is live. Check it out!

Sundrug Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sundrug and similar public comparables like Fragua, Ebos Group, COSMOS Pharmaceutical, DaShenLin Pharmaceutical and more.

Sundrug Overview

About Sundrug

Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.


Founded

1965

HQ

Japan

Employees

16.5K

Sectors

Financials (LTM)

Revenue: $5B
EBITDA: $421M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Sundrug Financials

Sundrug reported last 12-month revenue of $5B and EBITDA of $421M.

In the same LTM period, Sundrug generated $700M in gross profit, $421M in EBITDA, and $202M in net income.

Revenue (LTM)


Sundrug P&L

In the most recent fiscal year, Sundrug reported revenue of $5B and EBITDA of $426M.

Sundrug is profitable as of last fiscal year, with gross margin of 24%, EBITDA margin of 8%, and net margin of 4%.

See analyst estimates for Sundrug
LTMLast FY202320242025202620272028
Revenue$5B$5B$5B$5B$5B
Gross Profit$700M$1B$1B$1B$844M
Gross Margin13%24%25%25%16%
EBITDA$421M$426M$349M$381M$411M
EBITDA Margin8%8%7%8%8%
EBIT Margin6%6%5%6%6%
Net Profit$202M$211M$180M$193M$199M
Net Margin4%4%4%4%4%

Financial data powered by Morningstar, Inc.

Sundrug Stock Performance

Sundrug has current market cap of $3B, and enterprise value of $3B.

Market Cap Evolution


Sundrug's stock price is $23.96.

Sundrug share price increased by 1.7% in the last 30 days, and decreased by 15.2% in the last year.

Sundrug has an EPS (earnings per share) of $1.80.

See more trading valuation data for Sundrug
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$3B0.0%1.7%-9.9%-15.2%$1.80

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Sundrug Valuation Multiples

Sundrug trades at 0.5x EV/Revenue multiple, and 6.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Sundrug

EV / Revenue (LTM)


Sundrug Financial Valuation Multiples

As of May 4, 2026, Sundrug has market cap of $3B and EV of $3B.

Sundrug has a P/E ratio of 13.9x.

LTMLast FY202320242025202620272028
EV/Revenue0.5x0.5x0.6x0.5x0.5x
EV/EBITDA6.3x6.3x7.7x7.0x6.5x
EV/EBIT8.9x8.8x10.5x9.6x9.1x
EV/Gross Profit3.8x2.1x2.3x2.1x3.2x
P/E13.9x13.3x15.6x14.5x14.1x
EV/FCF37.0x60.8x83.2x70.9x41.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Sundrug Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Sundrug Margins & Growth Rates

Sundrug decreased revenue by 2% and EBITDA by 2% in the last fiscal year.

In the most recent fiscal year, Sundrug reported gross margin of 24%, EBITDA margin of 8%, and net margin of 4%.

See estimated margins and future growth rates for Sundrug

Sundrug Margins

Last FY202420252026202720282029
Gross Margin24%25%16%13%
EBITDA Margin8%8%8%8%
EBIT Margin6%6%6%6%
Net Margin4%4%4%4%
FCF Margin1%1%1%1%

Sundrug Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(2%)7%6%7%
Gross Profit Growth(47%)8%(34%)(10%)
EBITDA Growth(2%)9%8%7%
EBIT Growth(2%)9%6%8%
Net Profit Growth(5%)7%3%8%
FCF Growth61%17%70%32%

Data powered by FactSet, Inc. and Morningstar, Inc.

Sundrug Operational KPIs

Sundrug's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Sundrug's Rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Sundrug's Rule of X is 26% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Sundrug
LTMLast FY202320242025202620272028
Rule of 4015%15%
Bessemer Rule of X27%26%
Revenue per Employee$0.3M
Opex per Employee$0.1M
Opex to Revenue18%20%20%19%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Sundrug Competitors

Sundrug competitors include Fragua, Ebos Group, COSMOS Pharmaceutical, DaShenLin Pharmaceutical, Kusuri No Aoki, Sugi Holdings, Nahdi Medical, Omnicell, Clicks Group and Dis-Chem Pharmacies.

Most Sundrug public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Fragua0.4x0.3x7.0x4.4x
Ebos Group0.5x0.4x10.7x8.4x
COSMOS Pharmaceutical0.5x0.5x7.7x7.7x
DaShenLin Pharmaceutical0.7x0.7x5.4x5.5x
Kusuri No Aoki0.8x0.8x10.4x10.9x
Sugi Holdings0.6x0.5x9.7x7.9x
Nahdi Medical1.4x1.4x8.5x8.4x
Omnicell1.6x1.6x13.6x12.9x

This data is available for Pro users. Sign up to see all Sundrug competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Sundrug

When was Sundrug founded?Sundrug was founded in 1965.
Where is Sundrug headquartered?Sundrug is headquartered in Japan.
How many employees does Sundrug have?As of today, Sundrug has over 16K employees.
Who is the CEO of Sundrug?Sundrug's CEO is Hiroshi Sadakata.
Is Sundrug publicly listed?Yes, Sundrug is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Sundrug?Sundrug trades under 9989 ticker.
When did Sundrug go public?Sundrug went public in 1997.
Who are competitors of Sundrug?Sundrug main competitors include Fragua, Ebos Group, COSMOS Pharmaceutical, DaShenLin Pharmaceutical, Kusuri No Aoki, Sugi Holdings, Nahdi Medical, Omnicell, Clicks Group, Dis-Chem Pharmacies.
What is the current market cap of Sundrug?Sundrug's current market cap is $3B.
What is the current revenue of Sundrug?Sundrug's last 12 months revenue is $5B.
What is the current revenue growth of Sundrug?Sundrug revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Sundrug?Current revenue multiple of Sundrug is 0.5x.
Is Sundrug profitable?Yes, Sundrug is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Sundrug?Sundrug's last 12 months EBITDA is $421M.
What is Sundrug's EBITDA margin?Sundrug's last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of Sundrug?Current EBITDA multiple of Sundrug is 6.3x.
What is the current FCF of Sundrug?Sundrug's last 12 months FCF is $72M.
What is Sundrug's FCF margin?Sundrug's last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Sundrug?Current FCF multiple of Sundrug is 37.0x.
How many companies Sundrug has acquired to date?Sundrug hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Sundrug has invested to date?Sundrug hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Sundrug

Lists including Sundrug

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial